Covalent Partners’s COVA Acquisition Corp. Warrants to purchase Class A ordinary shares COVAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-75,000
Closed -$2K 46
2022
Q3
$2K Hold
75,000
﹤0.01% 46
2022
Q2
$8K Hold
75,000
0.01% 39
2022
Q1
$14K Hold
75,000
0.01% 49
2021
Q4
$37K Hold
75,000
0.03% 53
2021
Q3
$44K Hold
75,000
0.07% 42
2021
Q2
$67K Buy
+75,000
New +$52.2K 0.06% 47

Covalent Partners's COVAW Position: Q4 2022 in Review

Covalent Partners sold out of COVA Acquisition Corp. Warrants to purchase Class A ordinary shares (COVAW) in Q4 2022, closing a stake of 75,000 shares — an estimated $2K sold.

Covalent Partners first reported a position in COVAW in Q2 2021 and held it in 6 quarters. The position peaked at $67K in Q2 2021. 0 funds tracked by Wall St. Rank hold COVAW as of Q4 2022.

  • Covalent Partners reported no remaining COVA Acquisition Corp. Warrants to purchase Class A ordinary shares position as of Q4 2022 after selling out during the quarter.
  • Covalent Partners sold 75,000 COVA Acquisition Corp. Warrants to purchase Class A ordinary shares shares in Q4 2022, an estimated $2K.
  • Covalent Partners first reported a position in COVA Acquisition Corp. Warrants to purchase Class A ordinary shares in Q2 2021 and held it in 6 quarters.
  • Covalent Partners's COVA Acquisition Corp. Warrants to purchase Class A ordinary shares position peaked at $67K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held COVA Acquisition Corp. Warrants to purchase Class A ordinary shares as of Q4 2022.

Based on Covalent Partners's 13F filing for Q4 2022, filed 14 Feb 2023.